您的位置: 首页 > 农业专利 > 详情页

BOTULINUM TOXIN DOSAGE REGIMEN FOR CHRONIC MIGRAINE PROPHYLAXIS
专利权人:
ALLERGAN; INC.
发明人:
TURKEL, CATHERINE C.,AURORA, SHEENA K.,DODICK, DAVID W.,BRIN, MITCHELL F.
申请号:
MYPI 2012004288
公开号:
MY156827A
申请日:
2011.03.29
申请国别(地区):
MY
年份:
2016
代理人:
摘要:
DISORDERS SUCH AS HEADACHES CAN BE TREATED BY ADMINISTRATION OF A BOTULINUM TOXIN TO A PATIENT SUFFERING THEREFROM, SUCH AS A MIGRAINE HEADACHE. A COMBINED A FIXED SITE/FIXED DOSE AND AN OPTIONAL FOLLOW THE PAIN VARIABLE DOSAGE AND INJECTION SITE PARADIGM IS DISCLOSED FOR OPTIMIZING CLINICAL EFFECTIVENESS OF BOTULINUM TOXIN ADMINISTRATION FOR PATIENTS SUFFERING FROM CHRONIC MIGRAINE. THE INJECTION SCHEDULE REQUIRES A MINIMUM DOSE OF 155 U USING A FIXED-SITE, FIXED- DOSE INJECTION REGIMEN INTO 31-39 SITES ACROSS 7 HEAD/NECH MUSCLES, NAMELY THE FRONTALIS, CORRUGATOR, PROCERUS, OCCIPITALIS, TEMPORALIS, TRAPEZIUS AND CERVICAL PARASPINAL MUSCLES.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充